Overview

A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Status:
Recruiting

Trial end date:
2023-11-23

Target enrollment:

Participant gender:

Summary

This is a multicenter, open-label, parallel-group study to evaluate INCB054707 in participants with varying levels of renal function or impairment.

Phase:

Phase 1

Details

Lead Sponsor:

Incyte Corporation